Nucleus Basalis Of Meynert Cholinergic Neurons In Alzheimer'S Disease is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The nucleus basalis of Meynert (NBM) provides the primary cholinergic innervation to the cerebral cortex and is severely affected in Alzheimer's disease. Loss of these neurons contributes to memory deficits and cortical dysfunction. [1]
| Property | Value | [2]
|----------|-------| [3]
| Cell Type | Cholinergic Projection Neurons | [4]
| Location | Basal Forebrain (Nucleus Basalis of Meynert, Ch4) |
| Neurotransmitters | Acetylcholine |
| Associated Diseases | Alzheimer's Disease, Dementia with Lewy Bodies |
| Model Systems | 3xTg-AD mice, iPSC-derived cholinergic neurons |
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000108 | cholinergic neuron |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000108 | cholinergic neuron | Medium |
| Cell Ontology | CL:2000056 | Meynert cell | Medium |
The study of Nucleus Basalis Of Meynert Cholinergic Neurons In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Mesulam et al. Cholinergic innervation of the human cerebral cortex (2004). 2004. ↩︎
Schliebs & Arendt, The significance of the cholinergic system in AD (2011). 2011. ↩︎
Hampel et al. Cholinergic therapies for Alzheimer's disease (2018). 2018. ↩︎
Beach et al. Cholinergic neuron loss in the nucleus basalis of Meynert (2020). 2020. ↩︎